|
Conivaptan |
1,2,3,4-Tetrahydro-benzo[b]azepin-5-one |
1127-74-8 |
|
|
4-[(Biphenyl-2-ylcarbonyl)amino]benzoic acid |
168626-74-2 |
|
Purity aligned with route demands — Every lot is released against verified specifications covering HPLC purity (≥98%), appearance, and identity. Optimized processes for the N-toluenesulfonyl benzodiazepine-5-ketone intermediate have achieved purities of 99% and above.
Documentation that travels with the batch — A Certificate of Analysis (COA) with batch-specific data, Safety Data Sheet (SDS), and customs paperwork accompany each shipment. Tailored documentation packages can be arranged for ANDA/NDA submissions.
Quantities that match your stage — Milligram reference standards for analytical method development through kilogram-scale batches for process validation and commercial production.
Chemistry support when you need it — Our process chemists can help with route selection, impurity mapping, and analytical method design for conivaptan-related work.
Share your target intermediate and required specifications — we will come back quickly with availability, pricing, and lead times.
